UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032012
Receipt number R000035399
Scientific Title Construction of monitoring camera system for medical use with the function of recogniting the facial imformation.
Date of disclosure of the study information 2022/04/01
Last modified on 2019/04/21 15:40:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Construction of monitoring camera system for medical use with the function of recogniting the facial imformation.

Acronym

Construction of the medical monitoring camera system.

Scientific Title

Construction of monitoring camera system for medical use with the function of recogniting the facial imformation.

Scientific Title:Acronym

Construction of the medical monitoring camera system.

Region

Japan


Condition

Condition

The patients aged 20 years or older who are entered at the intensive care unit.

Classification by specialty

Intensive care medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to construct a camera system with the function to automatically evaluate the scale of analgesia or sedation using face information.

Basic objectives2

Others

Basic objectives -Others

Development of camera system with AI
Evaluation of the effectiveness

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome is the correct answers rate of the prediction model which is constructed the machine learning.
The correct answer of the prediction model is as follow,
RASS, BPS: perfect maching or difference within 1 point.
VAS: perfect maching or difference within 10mm.
GCS: The maching of the 2 or full items
After the second year of research, we will incorporate the data obtained in the previous year into the model, and update the evaluation of the accuracy rate every year.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

All patients entering the intensive care unit

Key exclusion criteria

Patients who are unable to agree to participate in this study
Patients deemed inappropriate as subjects by physicians

Target sample size

1400


Research contact person

Name of lead principal investigator

1st name shunsuke
Middle name
Last name Takaki

Organization

Yokohama city university school of medecine

Division name

Department of Anesthesiology and Critical Care Medicine

Zip code

2360004

Address

3-9, Fukuura, Kanazawa-ku, Yokohama, Japan

TEL

+81457872800

Email

shunty5323@gmail.com


Public contact

Name of contact person

1st name Shunsuke
Middle name
Last name Takaki

Organization

Yokohama city university school of medecine

Division name

Department of Anesthesiology and Critical Care Medicine

Zip code

2360004

Address

3-9, Fukuura, Kanazawa-ku, Yokohama, Japan

TEL

+81457872800

Homepage URL


Email

shunty5323@gmail.com


Sponsor or person

Institute

Yokohama city university school of medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Strategic Information and Communications R&D Promotion Programme (SCOPE)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The institutional ethics committee of the Yokohama City University Hospital

Address

3-9, Fukuura, Kanazawa-ku, Yokohama, Japan

Tel

+81453707627

Email

rinri@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 12 Month 28 Day

Date of IRB

2017 Year 11 Month 16 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The collection of the data from medical record; patient characterisitics (i.e. height, weight, sex, American society of Anesthesiologists Physical Status, complications [i.e. hyper tension, dibetes, cerebral infarction, dementia, and other neurlogical disease], ope information, and physical findings of head and neck [i.e. intubation, denture, tape, gauze, medical equipment, or tumor].
The facial imformation data is aquired from the bd side medical camera. The sedative or pain scale are evaluted by the nurse who are not related the data analysis. These data are collected at fixed intervals. The data of facial information, sedative or pain scale data, and vitai signs data at the same time are matched. Then these data are used for the machine learning.
The the data pairs are collected at 5 to 10 times per day.
The cohort of the first year is devoted to data collection for constructing an initial prediction model. From the next year, we will randomly divide into cohorts to construct prediction models and cohorts to confirm the validity of prediction models built up to the previous year. We will improve the prediction model accuracy of artificial intelligence using the data obtained every fiscal year and examine data collection and validity in the following year.



Management information

Registered date

2018 Year 03 Month 30 Day

Last modified on

2019 Year 04 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035399